Cheminformatic Tools and Databases for Pharmacology

session 37936 - Total of 4 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
FAMCICLOVIR (has an active metabolite)

FAMCICLOVIR


ATC J05AB09
ATC S01AD07

ANTIINFECTIVES
ANTIVIRAL
DNA POLYMERASE INHIBITOR
PRODRUG OF PENCICLOVIR
TREATMENT OF HERPES VIRUS HSV-1 AND HSV-2

ORAL

F 77 PERCENT

SOLUBILITY IS FREELY SOLUBLE (>25 PERCENT) IN WATER INITIALLY BUT RAPIDLY PRECIPITATES AS THE SPARINGLY SOLUBLE (2-3 PERCENT) MONOHYDRATE

HUMAN HERPESVIRUS 1 DNA POLYMERASE INHIBITOR CHEMBL1872 HUMAN HERPESVIRUS 1 DNA POLYMERASE P04293 DNA POLYMERASE CATALYTIC SUBUNIT HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17) ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PENCICLOVIR (is an active metabolite)

PENCICLOVIR


ATC D06BB06
ATC J05AB13

ANTIINFECTIVES
ANTIVIRAL
TREATMENT OF HERPES VIRUS HSV-1 AND HSV-2

- HSV POLYMERASE

HUMAN HERPESVIRUS 1 DNA POLYMERASE INHIBITOR CHEMBL1872 HUMAN HERPESVIRUS 1 DNA POLYMERASE P04293 DNA POLYMERASE CATALYTIC SUBUNIT HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17) ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

3 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M PENCICLOVIR (is an active metabolite)

PENCICLOVIR


ATC D06BB06
ATC J05AB13

ANTIINFECTIVES
ANTIVIRAL
TREATMENT OF HERPES VIRUS HSV-1 AND HSV-2

- HSV POLYMERASE

HUMAN HERPESVIRUS 1 DNA POLYMERASE INHIBITOR CHEMBL1872 HUMAN HERPESVIRUS 1 DNA POLYMERASE P04293 DNA POLYMERASE CATALYTIC SUBUNIT HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17) ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

4 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
PENCICLOVIR (is an active metabolite) (has an active metabolite)

PENCICLOVIR


ATC D06BB06
ATC J05AB13

ANTIINFECTIVES
ANTIVIRAL
TREATMENT OF HERPES VIRUS HSV-1 AND HSV-2

TOPICAL

Cmax 15.8 MICROMOLAR

Tmax 0.7 HOUR

VD 71.5 LITER (65 KILOGRAM)

PPB 14 PERCENT

Cl 32.7 LITER / HOUR (65 KILOGRAM)

HT 2.1 HOUR

SOLUBILITY OF 1.7 MILLIGRAM / MILLILITER IN WATER

THYMIDINE KINASE

HUMAN HERPESVIRUS 1 DNA POLYMERASE INHIBITOR CHEMBL1872 HUMAN HERPESVIRUS 1 DNA POLYMERASE P04293 DNA POLYMERASE CATALYTIC SUBUNIT HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17) ENZYME TRANSFERASEANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |